NIRVA

Nirva Institute · Astrocytes · Future Science

Astrocytes and Precision Medicine

Region- and subtype-specific therapies on the horizon.

The Nirva InstitutePublished 20265 min read
Save

The heterogeneity of astrocytes across brain regions and disease states is both an obstacle and a resource for precision medicine — offering the possibility of interventions tailored to specific astrocyte subtypes.

§ 1

Subtype-specific targeting

Emerging viral and genetic tools allow investigators to target defined astrocyte subpopulations with increasing precision.180,216



Scientific References

Primary literature

AMA numeric style. Citation numbers are unified across the Nirva Life ecosystem — the same number refers to the same reference across every library article. Full registry is anchored in the Cornerstone Paper.

  1. 180.Khakh BS, Deneen B. The emerging nature of astrocyte diversity. Annu Rev Neurosci. 2019;42:187-207. PubMed ↗
  2. 216.Kastanenka KV, Moreno-Bote R, De Pittà M, et al. A roadmap to integrate astrocytes into systems neuroscience. Glia. 2020;68(1):5-26. PubMed ↗

Next Recommended Reading

Astrocytes and Longevity Research

Aging brains and the changing glial environment.

Continue Reading